跳至主要内容
临床试验/PACTR202109714591017
PACTR202109714591017尚未招募未知

Effect of heparin reversal by protamine sulfate on the outcome of thrombolysis in acute ischemic stroke after percutaneous coronary intervention

neurology department ain shams university0 个研究点目标入组 60 人开始时间: 2021年9月20日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • 1. Adults (~18 years or over) undergoing elective or emergency PCI.
  • 2.Acute ischemic stroke, defined as focal neurological deficit occurring during or immediately after PCI, and diagnosed by an expert neurologist.
  • 3.Stroke within 4 hours of onset.
  • 4.National institutes of health stroke scale (NIHSS) ranging from 4-15.
  • 5.NIHSS < 4 if causing strategic deficit (e.g.: aphasia).
  • 6.CT brain is negative for hemorrhage.
  • 7.Patients fulfilled the inclusion criteria for TPA.
  • 8.All participants or their relatives give written consent for participation in this study.

排除标准

  • 1-Adolescents or children (<18 years).
  • 2-Patients who develop intracranial hemorrhagic stroke.
  • 3-Large ischemic stroke (NIH >15).
  • 4-Mild neurological deficit (NIH <3) and no strategic deficit.
  • 5-Stroke onset beyond 4.5 hours
  • 6-Exclusion criteria for TPA

研究者

发起方
neurology department ain shams university

相似试验

Effect of heparin reversal by protamine sulfate on... | 临床试验